All News

Collaborations, Mergers & Acquisitions

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment
21 September 2023
Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment
Taysha is discontinuing the development
Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux
20 September 2023
Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux
Oxford Biomedica in Exclusive Talks
LEXEO Therapeutics Attains Strategic Investment from Sarepta Therapeutics to Support LEXEO’s Cardiovascular Gene Therapies
29 August 2023
LEXEO Therapeutics Attains Strategic Investment from Sarepta Therapeutics to Support LEXEO’s Cardiovascular Gene Therapies
LEXEO Therapeutics attains strategic investment
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
17 August 2023
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
Precision BioSciences Completes Strategic Transaction
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

Mustang Bio Announces Amendment and Closing of Manufacturing Partnership with uBriGene (Boston)
1 August 2023
Mustang Bio Announces Amendment and Closing of Manufacturing Partnership with uBriGene (Boston)
Mustang Bio has announced the
RenovoRx and Imugene Collaborate to Deliver Oncolytic Virus Therapy Using Proprietary Platform
21 July 2023
RenovoRx and Imugene Collaborate to Deliver Oncolytic Virus Therapy Using Proprietary Platform
RenovoRx and Imugene announce their
Cell Sorter for Next Cell Therapy Products: The Sangamo & Sony Biotechnology Journey
20 July 2023
Cell Sorter for Next Cell Therapy Products: The Sangamo & Sony Biotechnology Journey
This Briefing from Advanced Therapies
Scribe and Sanofi Expand Collaboration Further to Advance Genetic Treatments
18 July 2023
Scribe and Sanofi Expand Collaboration Further to Advance Genetic Treatments
Scribe and Sanofi Expand Collaboration
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map